Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations

Affiliations

• ¹ Department of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.
• ² Department of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain; Pharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain.
• ³ Pharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain; Department of Urology, Hospital Clínic Barcelona, Barcelona, Spain.
• ⁴ Department of Urology, Hospital Clínic Barcelona, Barcelona, Spain.
• ⁵ Department of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Spain.
• ⁶ Department of Pathology, Hospital Clínic Barcelona, Barcelona, Spain.
• ⁷ Pharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain; Department of Immunology, Hospital Clínic Barcelona, Barcelona, Spain.
• ⁸ Department of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Spain; Pharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Raras CIBERER, Instituto Salud Carlos III, Spain. ccarrera@clinic.cat.